Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
07/1999
07/27/1999CA2158853C New anti viral compounds
07/27/1999CA1340678C Antiparasitic avermectin derivatives
07/22/1999WO1999036429A2 Nucleobase oligomers
07/22/1999CA2317677A1 Nucleobase oligomers
07/21/1999EP0930315A1 Lewis x derivatives
07/21/1999EP0930069A2 Compositions for the reduction of scarring
07/21/1999EP0929551A1 New pharmaceutically active compounds
07/21/1999EP0929538A1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/21/1999EP0929218A2 P2y receptor antagonists
07/21/1999CN1223261A Novel 2-thiosubstituted carbapenems
07/20/1999US5925649 Ascomycins
07/20/1999US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage
07/20/1999US5925525 Method of identifying nucleotide differences
07/20/1999US5925190 Heating with pyrolysis insulin in the pyrolysis of insulin
07/15/1999WO1999034804A1 A2a adenosine receptor agonists
07/15/1999CA2317093A1 A2a adenosine receptor agonists
07/14/1999CN1044119C Process for purifying and isolating 2'-deoxy-2,2' difluoronucleosides
07/13/1999US5922860 Antitumor indolopyrrolocarbazole derivatives
07/13/1999US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems
07/13/1999US5922350 Dehydration in presence of sugars present at a protectiveconcentration on both inside and outside surfaces; liposomeshave ion concentration gradient capable of generatingtransmember potential to load charged material
07/13/1999CA2258445A1 Compositions for the reduction of scarring
07/13/1999CA2033044C 6-substituted purine carbocyclic nucleosides
07/13/1999CA1340645C Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus
07/08/1999WO1999033476A1 Hyperhydrated citicoline, process and use
07/08/1999CA2316989A1 Hyperhydrated citicoline, process and use
07/07/1999EP0927189A1 Processes for high-yield diastereoselective synthesis of dideoxynucleosides
07/07/1999EP0927180A1 Heterocyclic compounds and their use for isolating nucleic acids
07/07/1999EP0927178A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
07/07/1999EP0601092B1 Method for the selection of genetically transformed cells and compounds for use in the method
07/07/1999CN1222192A Antisense inhibitors of vascular endothelial growth factor (VEFG/VPF) expression
07/07/1999CN1222157A Processes for high-yield diastereoselective synthesis of dideoxynucleosides
07/07/1999CN1043997C 2,6-diaminopurine derivatives, its use and medicinal compsns. containing same
07/07/1999CN1043996C Antiparasitic agents and its prepn. method and use
06/1999
06/30/1999EP0891393B1 Asymmetric benzoxanthene dyes
06/30/1999CN1221423A Intermediates for oligonucleotide synthesis
06/29/1999US5917040 2-fluoro-9-trimethylsilyladenine
06/29/1999CA2130275C Use of substituted adenine derivatives for treating multiple sclerosis
06/24/1999WO1999031935A1 Apparatus and method for a custom soft-solid hearing aid
06/24/1999WO1999031934A1 Compliant hearing aid and method of manufacture
06/24/1999WO1999031431A1 Method for determining a base sequence of a nucleotide strand
06/24/1999WO1999031280A1 Screening assays for the detection and diagnosis of influenza virus
06/24/1999WO1999031267A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
06/24/1999WO1999030561A1 Nucleotide-based prodrugs
06/24/1999WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
06/24/1999CA2314890A1 Apparatus and method for a custom soft-solid hearing aid
06/24/1999CA2314889A1 Compliant hearing aid and method of manufacture
06/24/1999CA2314431A1 Screening assays for the detection and diagnosis of influenza virus
06/24/1999CA2314422A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
06/23/1999EP0923597A1 Substituted propargylethoxyamido nucleosides
06/23/1999EP0923595A1 Nucleic acid mediated electron transfer
06/23/1999EP0923591A1 Novel boronic acid-containing nucleic acids and their use as diagnostic agents
06/23/1999CN1220605A Nucleotide analogues for topical treatment of proliferative disease of skin
06/23/1999CN1043769C L-nucleosides for treatment of hepatitis B-virus and epstein-bar virus and its use
06/23/1999CN1043768C Avermectin derivative, its preparing method and use, and drug composition containing said derivative
06/22/1999US5914400 Method and compositions for the synthesis of BCH-189 and related compounds
06/22/1999US5914396 2'-O-modified nucleosides and phosphoramidites
06/22/1999US5914331 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
06/17/1999WO1999029710A2 Purification method for producing fludarabin phosphate
06/17/1999WO1999029702A2 METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA)
06/17/1999WO1999015541A3 Use of a pentopyranosyl nucleoside for producing an electronic component, and conjugates of said pentopyranosyl nucleoside
06/17/1999WO1999015539A3 Pentopyranosyl nucleoside, and production and use of the same
06/17/1999CA2313486A1 Purification method for producing fludarabin phosphate
06/16/1999CN1219541A Preparation and usage of antisense digonucleotides
06/16/1999CN1043646C Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
06/15/1999US5912366 α, α-Difluoro-β-hydroxy thiol esters and their synthesis
06/15/1999US5912238 Heteroatoms-containing tricyclic compounds
06/10/1999WO1999015540A3 Method for producing a pentopyranosyl nucleoside
06/09/1999EP0921121A1 Intermediates to therapeutic nucleosides
06/09/1999EP0921114A1 Intermediates to therapeutic nucleosides
06/09/1999EP0920438A2 N6 heterocyclic substituted adenosine derivatives
06/03/1999WO1999027138A1 Nucleic acid ligands of tissue target
06/03/1999WO1999027020A1 Dibenzorhodamine dyes useful as flourescent labelling agents
06/03/1999WO1999026958A1 Nucleoside analog compositions and uses thereof
06/03/1999WO1999012951A8 Uses of nicotinamide adenine dinucleotide and its analogs for treatment of malignant and infectious diseases
06/03/1999WO1999006422A3 Base analogues
06/03/1999CA2311581A1 Nucleoside analog compositions and uses thereof
06/03/1999CA2311164A1 Nucleic acid ligands of tissue target
06/02/1999EP0918784A1 Alkylated nucleoside-3'-phosphates, process for producing them and their use
06/01/1999US5908926 Immobilization; radiation
05/1999
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/26/1999EP0781293A4 Compositions for enzyme catalyzed template-independent creation of phosphodiester bonds using protected nucleotides
05/26/1999CN1217335A Method for preparing precursor medicine
05/25/1999CA2205218C Improved methods for h-phosphonate synthesis of mono- and oligonucleotides
05/20/1999WO1999024452A2 Pyrimidine derivatives for labeled binding partners
05/20/1999WO1999024451A2 Adenosine a1 receptor agonists
05/20/1999WO1999024450A2 Adensine a1 receptor agonists
05/20/1999WO1999024449A2 Adenosine a1 receptor agonists
05/20/1999WO1999010369A9 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/20/1999DE19750508A1 New phospholipid-nucleoside adducts useful for treating and preventing mammary tumors and leukemia
05/20/1999CA2309200A1 Adenosine a1 receptor agonists
05/20/1999CA2309199A1 Adensine a1 receptor agonists
05/19/1999EP0916737A2 Polynucleotide compounds for hybridizing to target polynucleotides
05/19/1999EP0915935A1 4,7-dichlororhodamine dyes
05/19/1999EP0915901A1 Propargylethoxyamino nucleotides
05/19/1999EP0915900A1 Process for the preparation of ivermectin
05/19/1999CN1216766A Method for preparing beta-thymidine
05/18/1999US5905144 Preparing synergistic anti-hiv drugs by linking nucleoside compound like ribavirin to zidovudine, 2',3'-dideoxyinosine, or 3'-dioxy-2',3'-didehydrothymidine with diacid chloride forming diester compound
05/18/1999US5905070 5--Caboxamido or 5--fluoro!-- 2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides
05/14/1999WO1999023104A2 Antitumour uridine analogues